INSM: Insmed Incorporated Stock

by  •  • Comments Off on INSM: Insmed Incorporated Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 12,748.61
Enterprise Value ($M) 13,626.48
Book Value ($M) 483.42
Book Value / Share 2.70
Price / Book 26.37
NCAV ($M) 80.29
NCAV / Share 0.45
Price / NCAV 158.79

Profitability (mra)
Return on Invested Capital (ROIC) -0.46
Return on Assets (ROA) -0.65
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 5.99
Current Ratio 6.37

Balance Sheet (mrq) ($M)
Current Assets 1,649.85
Assets 2,052.97
Liabilities 1,569.56
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
3 days ago 13G/A Price T Rowe Associates Inc /md/ 7.30 16.72
09-03 13G Darwin Global Management, Ltd. 5.70
02-16 13G/A T. Rowe Price Investment Management, Inc. 4.10 0.00
02-13 13G/A Vanguard Group Inc 9.87 -1.98
01-25 13G/A BlackRock, Inc. 8.00 3.41
01-22 13G/A State Street Corp 4.15 -13.89

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-10-31 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-02-22 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PUR

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-15 788,023 2,643,352 29.81
2024-11-14 215,740 1,337,232 16.13
2024-11-13 302,792 1,304,314 23.21
2024-11-12 302,366 1,412,404 21.41
2024-11-11 154,943 1,090,111 14.21

(click for more detail)

Similar Companies
INBX – Inhibrx Biosciences, Inc. INDV – Indivior PLC
INNV – InnovAge Holding Corp. INVA – Innoviva, Inc.
INZY – Inozyme Pharma, Inc.


Financial data and stock pages provided by
Fintel.io

Finpedia: Insmed